Iron addiction: A novel therapeutic target in ovarian cancer

Ovarian cancer is a lethal malignancy that has not seen a major therapeutic advance in over 30 years. We demonstrate that ovarian cancer exhibits a targetable alteration in iron metabolism. Ferroportin (FPN), the iron efflux pump, is decreased, and transferrin receptor (TFR1), the iron importer, is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncogene
Main Authors: Basuli, Debargha, Tesfay, Lia, Deng, Zhiyong, Paul, Bibbin, Yamamoto, Yusuke, Ning, Gang, Xian, Wa, McKeon, Frank, Lynch, Miranda, Crum, Christopher P., Hegde, Poornima, Brewer, Molly, Wang, Xiaohong, Miller, Lance D., Dyment, Nathaniel, Torti, Frank M., Torti, Suzy V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5540148/
https://ncbi.nlm.nih.gov/pubmed/28319068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados